Burcu Tunakan: Turning Collaboration into Better Outcomes for People with Hemophilia
Burcu Tunakan, Vice President of US Hematology and Endocrinology Franchise Lead at Pfizer, shared a post on LinkedIn:
“Today, we were thrilled to host our second Hemophilia Day at Pfizer Headquarters.
Leading Hematologists across the nation joined us for a day of candid dialogue and collaboration, at a time when the science in this space is advancing faster than ever.
We exchanged perspectives and insights which will shape our team’s actions to advance care for people living with Hemophilia.
Because there is still meaningful work ahead.
And our team is fully committed to turning breakthrough innovation into real, lasting patient impact, by listening deeply and working alongside this community every step of the way.
Thank you to every leading expert who joined us.
Your partnership makes the difference.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering